Myria Biosciences aims to reshape drug discovery with synthetic intelligence to engineer natural-product inspired chemical compounds for pharma and biotech challenges.
The company's GEMMS (Genetically Engineered Modular Molecule Scaffolds) platform combines synthetic biology and artificial intelligence into a synthetic intelligence approach that allows therapeutic compound design and biological production far beyond what nature's evolution has provided.
Myria is unlocking new chemical space and generating optimized molecular candidates with unprecedented speed and precision for unmet medical needs.
Company Details
- Employees
- 10
- Founded
- 2022
- Address
- Hochbergerstrasse 60c, Basel,4057,switzerland
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://www.myria.bio
- Keywords
- in a fast-paced.
- HQ
- Basel
Myria Biosciences Ag Questions
Myria Biosciences Ag's website is https://www.myria.bio
Myria Biosciences Ag's LinkedIn profile is https://ch.linkedin.com/company/myriabio
Myria Biosciences Ag has
10 employees.
View email and phone details for 10
employees at Myria Biosciences Ag.
Myria Biosciences Ag's industry is
Biotechnology Research
Myria Biosciences Ag's top competitors are
Apersys Ag,
Procavea Biotech,
Cellx Biosolutions,
Prevision Medicine,
A-Metal,
Zuriq,
Tandem Therapeutics,
Evis Bioscience Ag,
2hs Ag,
House Of Charts.
Myria Biosciences Ag's categories are Biotechnology Research
Myria Biosciences Ag's founding year is 2022
